^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

COMPANY:
Panagene

i
Other names: Panagene | PANAGENE | PANAGENE Inc. | PANAGENE Inc
Related tests:
Evidence

News

6ms
Panagene teams up with Yuhan to develop companion diagnostic for Leclaza (Korea Biomedical Review)
"Panagene said on Monday it signed a contract with Yuhan Corp. to jointly develop the original companion diagnostic (CDx), called PANAMutyper R EGFR, for Yuhan’s lung cancer drug Leclaza (lazertinib)....A Yuhan official said that pursuing clinical trials and licensing of PANAMutyper R EGFR as the original companion diagnosis of Leclaza together with Panagene, a leader in domestic companion diagnosis, will be a new milestone in the development of CDx in Korea."
Licensing / partnership
|
PANAMutyper™ R EGFR
|
Leclaza (lazertinib)